|
Volumn 15, Issue 6, 2014, Pages 470-474
|
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: A case series
|
Author keywords
Crizotinib; FISH; IHC; NSCLC; ROS1
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CRIZOTINIB;
ONCOPROTEIN;
PEMETREXED;
PROTEIN TYROSINE KINASE;
ROS1 PROTEIN;
UNCLASSIFIED DRUG;
PROTEIN KINASE INHIBITOR;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
ROS1 PROTEIN, HUMAN;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER PATIENT;
CASE STUDY;
CAUSE OF DEATH;
CELL ONCOGENE;
CLINICAL ARTICLE;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE REARRANGEMENT;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
LOBECTOMY;
LUNG ADENOCARCINOMA;
LYMPH NODE DISSECTION;
MEDIASTINUM LYMPHADENOPATHY;
MIDDLE AGED;
MONOTHERAPY;
TREATMENT RESPONSE;
ADENOCARCINOMA;
CANCER STAGING;
CASE REPORT;
DRUG RESISTANCE;
GENETICS;
LUNG NEOPLASMS;
MUTATION;
UPREGULATION;
ADENOCARCINOMA;
ADULT;
AGED;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE REARRANGEMENT;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LUNG NEOPLASMS;
MIDDLE AGED;
MUTATION;
NEOPLASM STAGING;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PROTO-ONCOGENE PROTEINS;
PYRAZOLES;
PYRIDINES;
UP-REGULATION;
|
EID: 84908200713
PISSN: 15257304
EISSN: 19380690
Source Type: Journal
DOI: 10.1016/j.cllc.2014.06.004 Document Type: Article |
Times cited : (14)
|
References (6)
|